Back
Protagonist Therapeutics Stock Predictions
Google closes secret $20B deal with Apple to become iPhone's default search engine
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
$51.33
Seasonality Move:
13.71%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Protagonist Therapeutics Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 65.8% based on the past 8 years of stock performance.
-
Protagonist Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Protagonist Therapeutics Stock Undervalued?The current Protagonist Therapeutics [PTGX] share price is $52.53. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 65.8% based on the past 8 years of stock performance.
Protagonist Therapeutics Stock Rating
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics overpriced?
-
Protagonist Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
60.60
52-Week Low:
24.22
Prediction Charts
Market Cap:
3.2B
Price in USD:
52.53
Volume:
1.5M
Beta:
2.07
Technical Analysis
SMA50:
41.17
SMA100:
41.93
SMA200:
40.77
52-Wk Change:
87.41%
Stock Predictions
-
Is Protagonist Therapeutics stock public?Yes, Protagonist Therapeutics is a publicly traded company.
-
What is the Protagonist Therapeutics stock quote today?The Protagonist Therapeutics stock price is 52.53 USD today.
-
How to buy Protagonist Therapeutics stock online?You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-4 | 38.24 | 38.70 | 39.70 | 37.63 |
| Mar-5 | 38.78 | 38.45 | 39.64 | 37.67 |
| Mar-6 | 37.92 | 39.05 | 39.40 | 37.92 |
| Mar-7 | 38.89 | 38.35 | 39.90 | 37.94 |
| Mar-11 | 55.90 | 59.76 | 60.14 | 54.12 |
| Mar-12 | 59.58 | 57.65 | 60.60 | 56.66 |
| Mar-13 | 57.90 | 54.90 | 58.70 | 54.79 |
| Mar-14 | 55.00 | 54.78 | 55.39 | 53.53 |
| Mar-17 | 54.16 | 53.01 | 54.25 | 52.26 |
| Mar-18 | 52.58 | 54.52 | 54.55 | 51.84 |
| Mar-19 | 54.45 | 54.35 | 54.54 | 52.43 |
| Mar-20 | 53.67 | 53.05 | 54.11 | 52.47 |
| Mar-21 | 53.23 | 52.65 | 53.23 | 51.06 |
| Mar-24 | 53.30 | 52.53 | 53.70 | 51.61 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.08 per share, a decrease this year of $3.86 per share, and an increase next year of $0.16 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.